• Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

KARO:SS

0.9700 SEK 0.00000.00%

As of 06:59:59 ET on 04/17/2014.

Snapshot for Karo Bio AB (KARO)

Open: 0.9700 Day's Range: 0.9500 - 0.9800 Volume: 862,465
Previous Close: 0.9700 52wk Range: 0.2466 - 1.1300 1-Yr Rtn: +235.47%

Stock Chart for KARO

No chart data available.
  • KARO:SS 0.9700
  • 1D
  • 1M
  • 1Y
0.9700
Interactive KARO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for KARO

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 22.5581
Relative P/E vs. OMX -
Earnings Per Share (SEK) (ttm) -0.0433
Est. EPS (SEK) (12/2014) 0.0430
Est. PEG Ratio -
Market Cap (M SEK) 481.07
Shares Outstanding (M) 495.95
30 Day Average Volume 9,862,282
Price/Book (mrq) 23.7292
Price/Sale (ttm) 13.4798
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for KARO

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for KARO

Karo Bio AB operates a drug research and development company. The Company develops precision drugs to treat major diseases in the field of nuclear receptors. Karo Bio works within many therapeutic areas including men and women's health, cardiovascular diseases, metabolic disorders and dermatology.

Goran WessmanChairmanPer BengtssonPresident & CEO
Lars OhmanVP:Business DevelopmentHenrik PalmChief Financial Officer
More Company Profile & Key Executives for KARO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil